It is my understanding from the professional services staff @Amgen that
they are in the early stages of testing the safety of rhe drug on a
sample population in Europe (on people without P D) This will take
about 6 months. To keep in touch with the progress use their web site
Amgen.Com...especially check the section on pipelines !
Do you know if the National Parkinson Foundation is aware of or involved
in this program ???
The Amgen people seem to think that the P D lobby is very large and
influential !
Keep in touch...
Anne Adams
